P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance

P3 Health Partners Inc. (NASDAQ: PIII) reported Q4 EPS of ($0.22), $0.14 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $346.9 million versus the consensus estimate of $302.97 million.

GUIDANCE:

P3 Health Partners Inc. sees FY2024 revenue of $1450-1550 million, versus the consensus of $1427 million.

For earnings history and earnings-related data on P3 Health Partners Inc. (PIII) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c